Egypts Glaucoma drug market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Glaucoma is one of the major eye disorders which results in damage to the optic nerve and can result in vision loss and blindness. It is usually caused by fluid building up in the front part of the eye, which increases pressure inside the eye.

According to the Egyptian Society for glaucoma disease, the incidence of glaucoma in Egypt is about 0.5% to 1% of the total population. In Egypt, more than half a million children and adolescents are estimated to be affected by glaucoma

Despite ongoing medical progress in treating the condition, early detection of patients is still necessary.



Market Drivers

Factors such as quick speed because of the some of the main factors for example the increasing prevalence of glaucoma diseases, growing of the old age population in Egypt has become one of the factors that will boost the growth of the glaucoma market in the forecast period. Several initiatives by the administration and healthcare organizations in order to cure glaucoma regarding the difficulties and suitable repayment rules regarding glaucoma treatment are anticipated to propel the growth in the glaucoma market in the forecast period.

Additionally, continuous inventions in the drugs and the increasing number of patients with diabetes are to extend profitable opportunities for the growth of the glaucoma market in the coming years.

However, the lack of alertness about the disease and its treatment and postoperative problems resulting after glaucoma surgery further challenge the growth of the glaucoma market in the coming years.